Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achaogen Inc (NASDAQ:AKAO)

3.99
Delayed Data
As of 3:59pm ET
 +0.18 / +4.72%
Today’s Change
2.59
Today|||52-Week Range
7.74
-30.49%
Year-to-Date
Pain Therapeutics (PTIE) Worth a Look: Stock Gains 7.6%
Jul 22 / Zacks.com - Paid Partner Content
Foamix Pharmaceuticals (FOMX) Jumps: Stock Rises 7.1%
Jul 15 / Zacks.com - Paid Partner Content
Ariad Pharmaceuticals (ARIA) In Focus: Stock Jumps 8.2%
Jul 21 / Zacks.com - Paid Partner Content
Loxo Oncology (LOXO) Looks Good: Stock Adds 6% in Session
Jul 14 / Zacks.com - Paid Partner Content
Cerulean Pharma (CERU) Worth a Look: Stock Gains 9.1%
Jul 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close3.81
Today’s open3.87
Day’s range3.82 - 4.01
Volume209,218
Average volume (3 months)298,108
Market cap$100.9M
Dividend yield--
Data as of 3:59pm ET, 07/27/2016

Growth & Valuation

Earnings growth (last year)-4.93%
Earnings growth (this year)-62.19%
Earnings growth (next 5 years)--
Revenue growth (last year)+30.50%
P/E ratioNM
Price/Sales4.00
Price/Book1.62

Competitors

 Today’s
change
Today’s
% change
CORICorium International...+0.20+4.47%
--EcoGreen Internation...+0.00+2.53%
NNVCNanoViricides Inc+0.04+2.35%
ORMPOramed Pharmaceutica...-0.08-1.00%
Data as of 4:02pm ET, 07/27/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$26.1M
Annual profit (last year)-$27.1M
Net profit margin-103.96%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO &
Class II Director
Kenneth J. Hillan
Chief Operating Officer
Blake Wise
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs